| Line item | 2025-09-28 FY | 2024-09-29 FY | 2023-10-01 FY | 2022-10-02 FY | 2021-10-03 FY |
|---|---|---|---|---|---|
| Revenue | $10.47M | $9.91M | $9.44M | $10.74M | $11.86M |
| Cost of Revenue | – | – | – | – | $1.49M |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $6.84M | $6.89M | $7.02M | $7.22M | $5.82M |
| Operating Income | $2.06M | -$1.38M | -$430.25K | $1.20M | $3.76M |
| Interest Expense | $219.34K | $229.24K | $222.40K | $261.62K | $335.94K |
| Tax Expense | $462.23K | -$385.32K | -$88.68K | $302.80K | $882.00K |
| Net Income | $1.46M | -$1.09M | -$483.74K | $727.49K | $2.80M |
| EPS (basic) | 1.9300 | -0.0100 | -0.0100 | 0.0100 | 0.0400 |
| EPS (diluted) | 1.9300 | -0.0100 | -0.0100 | 0.0100 | – |
| Shares (diluted) | $755.74K | $75.68K | $75.36K | $75.19K | – |